Home › Funds › Paradigm Biocapital Advisors LP › VOR
Paradigm Biocapital Advisors LP position in VOR
VOR BIOPHARMA INC · Health Care
Paradigm Biocapital Advisors LP reported holding 889,575 shares of VOR (VOR BIOPHARMA INC) in its Q3 2026 13F filing — a position valued at US$17.0M, representing 0.34% of its reported portfolio and ranking #26 among its reported holdings. Paradigm Biocapital Advisors LP has disclosed VOR holdings in 8 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Paradigm Biocapital Advisors LP's VOR position evolved
Paradigm Biocapital Advisors LP first disclosed a stake in VOR in Q3 2023 at 6,461,467 shares (US$13.7M). The position peaked in Q2 2026 at 1,750,000 shares, worth US$32.2M. Across 8 filings, Paradigm Biocapital Advisors LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 889,575 shares valued at US$17.0M — a reduction of -860,425 shares quarter over quarter.. Notable position changes include a 49% trim in Q3 2026 (shares rose 2% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 6.46M | $13.70M | New |
| Q4 2023 | 6.46M | $14.53M | Hold |
| Q1 2024 | 6.46M | $15.30M | Hold |
| Q2 2024 | 6.46M | $6.46M | Hold |
| Q4 2025 | 1.75M | $22.89M | New |
| Q1 2026 | 1.75M | $31.22M | Hold |
| Q2 2026 | 1.75M | $32.22M | Hold |
| Q3 2026 | 889.58K | $16.97M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VOR and 13F data
VOR (VOR BIOPHARMA INC) is a Health Care company. 70 other funds we track also report a position in VOR — the largest reported positions include TCG Crossover Management, LLC (US$108.2M), FCPM III SERVICES B.V. (US$65.0M), Venrock Adviser, LLC (US$56.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VOR
- TCG Crossover Management, LLC 5.67M sh · $108.24M · Q3 2026
- FCPM III SERVICES B.V. 3.41M sh · $64.97M · Q3 2026
- Venrock Adviser, LLC 3.04M sh · $56.00M · Q2 2026
- Frazier Life Sciences Management, L.P. 2.54M sh · $46.83M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 2.40M sh · $44.22M · Q2 2026
- Caligan Partners LP 1.93M sh · $35.44M · Q2 2026
- GREAT POINT PARTNERS LLC 1.70M sh · $31.30M · Q2 2026
- Nantahala Capital Management, LLC 931.64K sh · $17.78M · Q3 2026
- NAN FUNG TRINITY (HK) Ltd 721.55K sh · $13.77M · Q3 2026
- NEXTBio Capital Management LP 620.93K sh · $11.85M · Q3 2026
- Rosalind Advisors, Inc. 609.20K sh · $11.62M · Q3 2026
- Vivo Capital, LLC 550.36K sh · $10.50M · Q3 2026
More on Paradigm Biocapital Advisors LP
FAQ
How long has Paradigm Biocapital Advisors LP held VOR?
Paradigm Biocapital Advisors LP has disclosed VOR holdings in 8 of the last 13 reported quarters, going back to Q3 2023.
What is Paradigm Biocapital Advisors LP's current position in VOR?
As of Q3 2026, Paradigm Biocapital Advisors LP holds 889.58K shares of VOR (VOR BIOPHARMA INC), valued at $16.97M, representing 0.34% of its reported portfolio and ranking #26.
Has Paradigm Biocapital Advisors LP been buying or selling VOR?
In the latest 13F filing (Q3 2026), Paradigm Biocapital Advisors LP reduced its position in VOR. The position peaked in Q2 2026 at 1.75M shares.
Which other funds hold VOR?
Other major institutional holders of VOR include TCG Crossover Management, LLC, FCPM III SERVICES B.V., Venrock Adviser, LLC, among 70 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.